financetom
Business
financetom
/
Business
/
Xylem's Water Wisdom Pays Off: Q2 Beats Estimates, Outlook Upgraded
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Xylem's Water Wisdom Pays Off: Q2 Beats Estimates, Outlook Upgraded
Jul 30, 2024 7:41 AM

Xylem Inc. ( XYL ) shares are trading lower after it reported second-quarter FY24 results.

Revenue grew 26% Y/Y to $2.17 billion (+9% organically), beating the consensus of $2.145 billion on strong execution and demand.

By segment, Measurement & Control Solutions revenue was $482 million (+26% Y/Y), Water Infrastructure revenue was $631 million (+22% Y/Y), Applied Water revenue was $456 million (-5% Y/Y) and Water Solutions and Services was $600 million (+76% Y/Y).

Orders were up 12% Y/Y on a reported basis and declined 1% Y/Y organically to $2.09 billion.

The adjusted EBITDA margin reached 20.8%, up 170 basis points Y/Y, driven by productivity savings, higher volume, and price increases, which outweighed the effects of inflation, strategic investments, and mix changes.

Adjusted EPS was $1.09 (+14% Y/Y), beating the consensus of $1.05. 

Operating cash flow for six months ended June 30 stood at $377 million, compared to $9 million a year ago.

The company exited the year with cash and cash equivalents worth $815 million. 

Outlook: For FY24, Xylem raised the adjusted EPS outlook from $4.10-$4.25 to $4.18-$4.28 (versus the consensus of $4.21).

Also, the company revised its FY24 revenue outlook to $8.55 billion (consensus $8.56 billion), marking an increase of 16% Y/Y, with organic revenue growth expected to be 5%–6%, up from the previous range of 4%–6%.

Xylem’s President and CEO, Matthew Pine, said, “Healthy demand, combined with the team’s disciplined operational execution, delivered significant margin expansion in the quarter. Evoqua integration and synergies are also well on track.”

“We are confident in the team’s commitment to realizing our operational potential, and underlying demand in our largest markets remains resilient despite likely macro variability in the second half. Our diversified portfolio of mission-critical solutions is ideally positioned to meet global demand from intensifying water challenges.”

Investors can gain exposure to the stock via Global X Clean Water ETF ( AQWA ) and Invesco S&P Global Water Index ETF ( CGW ) .

Price Action: XYL shares are down 3% to $137.29 at the last check Tuesday.

Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
PTC Therapeutics Inks Licensing Pact With Novartis Worth Up To ~$3 Billion For Huntington's Program
PTC Therapeutics Inks Licensing Pact With Novartis Worth Up To ~$3 Billion For Huntington's Program
Dec 2, 2024
On Monday, PTC Therapeutics, Inc. ( PTCT ) signed an exclusive global license and collaboration agreement with Novartis AG ( NVS ) for its PTC518 Huntington’s disease program, which includes related molecules. Under the agreement, PTC will receive an upfront payment of $1.0 billion, up to $1.9 billion in development, regulatory and sales milestones, a profit share in the U.S., and double-digit tiered royalties...
Apple accused of silencing workers, spying on personal devices
Apple accused of silencing workers, spying on personal devices
Dec 2, 2024
Dec 2 (Reuters) - Apple ( AAPL ) has been accused in a new lawsuit of illegally monitoring its workers' personal devices and iCloud accounts while also barring them from discussing their pay and working conditions. The complaint filed in California state court on Sunday by Amar Bhakta, who works in digital advertising for Apple ( AAPL ), claims the...
Apple accused of silencing workers, spying on personal devices
Apple accused of silencing workers, spying on personal devices
Dec 2, 2024
(Reuters) - Apple ( AAPL ) has been accused in a new lawsuit of illegally monitoring its workers' personal devices and iCloud accounts while also barring them from discussing their pay and working conditions. The complaint filed in California state court on Sunday by Amar Bhakta, who works in digital advertising for Apple ( AAPL ), claims the company requires...
Pennsylvania pharmacies seek to centralize GoodRx antitrust claims in Rhode Island
Pennsylvania pharmacies seek to centralize GoodRx antitrust claims in Rhode Island
Dec 2, 2024
(Replaces older statement from CVS Caremark that was mistakenly used in paragraph 6 with current statement) By Brendan Pierson Nov 27 (Reuters) - Two independent pharmacies are seeking to centralize in Rhode Island federal court at least four proposed class action lawsuits accusing drug coupon aggregator GoodRx and pharmacy benefit managers, including CVS Caremark and Cigna's ( CI ) Express...
Copyright 2023-2026 - www.financetom.com All Rights Reserved